220 related articles for article (PubMed ID: 9210956)
1. Downregulation of aryl hydrocarbon receptor function and cytochrome P450 1A1 induction by expression of Ha-ras oncogenes.
Reiners JJ; Jones CL; Hong N; Clift RE; Elferink C
Mol Carcinog; 1997 Jun; 19(2):91-100. PubMed ID: 9210956
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells.
Spink DC; Spink BC; Cao JQ; DePasquale JA; Pentecost BT; Fasco MJ; Li Y; Sutter TR
Carcinogenesis; 1998 Feb; 19(2):291-8. PubMed ID: 9498279
[TBL] [Abstract][Full Text] [Related]
3. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status.
Angus WG; Larsen MC; Jefcoate CR
Carcinogenesis; 1999 Jun; 20(6):947-55. PubMed ID: 10357772
[TBL] [Abstract][Full Text] [Related]
4. Differential induction of Cyp1a1, Cyp1b1, Ahd4, and Nmo1 in murine skin tumors and adjacent normal epidermis by ligands of the aryl hydrocarbon receptor.
Reiners JJ; Jones CL; Hong N; Myrand SP
Mol Carcinog; 1998 Feb; 21(2):135-46. PubMed ID: 9496914
[TBL] [Abstract][Full Text] [Related]
5. 12-O-tetradecanoylphorbol-13-acetate upregulates the Ah receptor and differentially alters CYP1B1 and CYP1A1 expression in MCF-7 breast cancer cells.
Spink BC; Fasco MJ; Gierthy JF; Spink DC
J Cell Biochem; 1998 Sep; 70(3):289-96. PubMed ID: 9706865
[TBL] [Abstract][Full Text] [Related]
6. Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism.
Larsen MC; Angus WG; Brake PB; Eltom SE; Sukow KA; Jefcoate CR
Cancer Res; 1998 Jun; 58(11):2366-74. PubMed ID: 9622076
[TBL] [Abstract][Full Text] [Related]
7. Differentiation status of cultured murine keratinocytes modulates induction of genes responsive to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Jones CL; Reiners JJ
Arch Biochem Biophys; 1997 Nov; 347(2):163-73. PubMed ID: 9367521
[TBL] [Abstract][Full Text] [Related]
8. Induction of a chloracne phenotype in an epidermal equivalent model by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on aryl hydrocarbon receptor activation and is not reproduced by aryl hydrocarbon receptor knock down.
Forrester AR; Elias MS; Woodward EL; Graham M; Williams FM; Reynolds NJ
J Dermatol Sci; 2014 Jan; 73(1):10-22. PubMed ID: 24161567
[TBL] [Abstract][Full Text] [Related]
9. Expression of CYP1B1 but not CYP1A1 by primary cultured human mammary stromal fibroblasts constitutively and in response to dioxin exposure: role of the Ah receptor.
Eltom SE; Larsen MC; Jefcoate CR
Carcinogenesis; 1998 Aug; 19(8):1437-44. PubMed ID: 9744540
[TBL] [Abstract][Full Text] [Related]
10. Expression of cytochrome P450 (CYP) enzymes in human nonpigmented ciliary epithelial cells: induction of CYP1B1 expression by TCDD.
Volotinen M; Mäenpää J; Kankuri E; Oksala O; Pelkonen O; Nakajima M; Yokoi T; Hakkola J
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3099-105. PubMed ID: 19324859
[TBL] [Abstract][Full Text] [Related]
11. Metabolism-based polycyclic aromatic acetylene inhibition of CYP1B1 in 10T1/2 cells potentiates aryl hydrocarbon receptor activity.
Alexander DL; Zhang L; Foroozesh M; Alworth WL; Jefcoate CR
Toxicol Appl Pharmacol; 1999 Dec; 161(2):123-39. PubMed ID: 10581206
[TBL] [Abstract][Full Text] [Related]
12. The environmental toxin 2,3,7,8-tetrachlorodibenzo-p-dioxin induces cytochrome P450 activity in high passage PC 3 and DU 145 human prostate cancer cell lines.
Schaufler K; Haslmayer P; Jäger W; Pec M; Thalhammer T
Int J Mol Med; 2002 Apr; 9(4):411-6. PubMed ID: 11891538
[TBL] [Abstract][Full Text] [Related]
13. Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer.
Ishida M; Mikami S; Kikuchi E; Kosaka T; Miyajima A; Nakagawa K; Mukai M; Okada Y; Oya M
Carcinogenesis; 2010 Feb; 31(2):287-95. PubMed ID: 19755661
[TBL] [Abstract][Full Text] [Related]
14. Superinduction of CYP1A1 in MCF10A cultures by cycloheximide, anisomycin, and puromycin: a process independent of effects on protein translation and unrelated to suppression of aryl hydrocarbon receptor proteolysis by the proteasome.
Joiakim A; Mathieu PA; Elliott AA; Reiners JJ
Mol Pharmacol; 2004 Oct; 66(4):936-47. PubMed ID: 15385644
[TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor (AHR) and AHR nuclear translocator (ARNT) expression in Baikal seal (Pusa sibirica) and association with 2,3,7,8-TCDD toxic equivalents and CYP1 expression levels.
Kim EY; Iwata H; Suda T; Tanabe S; Amano M; Miyazaki N; Petrov EA
Comp Biochem Physiol C Toxicol Pharmacol; 2005 Jul; 141(3):281-91. PubMed ID: 16111922
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the mouse Cyp1B1 gene. Identification of an enhancer region that directs aryl hydrocarbon receptor-mediated constitutive and induced expression.
Zhang L; Savas U; Alexander DL; Jefcoate CR
J Biol Chem; 1998 Feb; 273(9):5174-83. PubMed ID: 9478971
[TBL] [Abstract][Full Text] [Related]
17. Expression of functional aromatic hydrocarbon receptor and aromatic hydrocarbon nuclear translocator proteins in murine bone marrow stromal cells.
Lavin AL; Hahn DJ; Gasiewicz TA
Arch Biochem Biophys; 1998 Apr; 352(1):9-18. PubMed ID: 9521805
[TBL] [Abstract][Full Text] [Related]
18. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells.
Döhr O; Vogel C; Abel J
Arch Biochem Biophys; 1995 Aug; 321(2):405-12. PubMed ID: 7646066
[TBL] [Abstract][Full Text] [Related]
19. Aryl hydrocarbon receptor expression and activity in cerebellar granule neuroblasts: implications for development and dioxin neurotoxicity.
Williamson MA; Gasiewicz TA; Opanashuk LA
Toxicol Sci; 2005 Feb; 83(2):340-8. PubMed ID: 15537747
[TBL] [Abstract][Full Text] [Related]
20. Disruption of clock gene expression alters responses of the aryl hydrocarbon receptor signaling pathway in the mouse mammary gland.
Qu X; Metz RP; Porter WW; Cassone VM; Earnest DJ
Mol Pharmacol; 2007 Nov; 72(5):1349-58. PubMed ID: 17715397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
